26 Clinical Trials for Hepatitis B Open for Enrollment
Safety and Efficacy of Adefovir Dipivoxil in Children and Adolescents with Chronic Hepatitis B Condition: Chronic Hepatitis B
A Study to Compare Tenofovir Versus Hepsera (Adefovir) for the Treatment of HBeAg Negative Chronic Hepatitis B Condition: Chronic Hepatitis B
Pegylated Interferon Alfa-2b Plus Ribavirin in Chronic Hepatitis B and Delta Conditions: Chronic Hepatitis B; Chronic Hepatitis D
Lamivudine and Adefovir to Treat Chronic Hepatitis B Conditions: HBV; Hepatitis B; Hepatitis; Liver
Comparison of Three Hepatitis B Vaccination Regimens in HIV-Positive Youth Conditions: HIV Infection; Hepatitis B
Lamivudine and Therapeutic Vaccine Evaluation in Senegalese Patients with Chronic Hepatitis B Infection Condition: Hepatitis B
Effectiveness of Two Hepatitis B Vaccines in HIV-Negative Youths Condition: Hepatitis B
Safety of and Immune Response to a Hepatitis B Virus Vaccine Given with a Booster (CpG7909 ODN) in HIV Infected and HIV Uninfected People Conditions: HIV Infections; Hepatitis B
Comparative Trial of Entecavir Versus Adefovir in the Treatment of Chronic Hepatitis B Infection Conditions: Hepatitis B; Chronic Disease
48 Weeks Combination Therapy for Patients with HBeAg-Negative Chronic Hepatitis B Virus (HBV) Infection Condition: Hepatitis B
Evaluate Efficacy, Safety and PK of Adefovir Dipivoxil Liquid Suspension in Patients with Chronic Hepatitis B Condition: Chronic Hepatitis B
Telbivudine Versus Lamivudine in Adults with Decompensated Chronic Hepatitis B and Evidence of Cirrhosis Conditions: Hepatitis; Hepatitis B, Chronic; Cirrhosis
Switching Therapy from Lamivudine to Telbivudine Vs Continued Lamivudine in Adults with Chronic Hepatitis B Condition: Chronic Hepatitis B
Telbivudine Versus the Combination of Telbivudine and Valtorcitabine in Patients with Chronic Hepatitis B Condition: Hepatitis B
FibroScan in Patients with Hepatitis B and C Presenting for Liver Biopsy Conditions: Cirrhosis; Hepatitis B; Hepatitis C
Prevention of Recurrent Hepatitis B After Liver Transplantation Conditions: Hepatitis B; Cirrhosis; Acute Liver Failure; Hepatocellular Carcinoma
Comparison of Entecavir to Adefovir in Chronic Hepatitis B Virus (HBV) Patients with Hepatic Decompensation Condition: Hepatitis B
Entecavir for Subjects with Chronic Hepatitis B Infection: An Early Access Program Conditions: Hepatitis B; Chronic Disease
Frequency of Parenteral and Non-Parenteral Exposures to Blood Among Healthcare Workers at the Clinical Center, NIH and at Seven Academic Hospitals in Japan Conditions: Hepatitis B; Hepatitis C; HIV Infection
Safety and Acceptability of a Vaginal Microbicide Conditions: HIV Infections; Hepatitis B, Chronic
Pentavalent DTaP-Hep B-IPV Conditions: Pertussis; Hepatitis B; Polio
Long-Term Lamivudine Therapy for Chronic Hepatitis B
Virological and Clinical Anti-HBV Efficacy of Tenofovir and Emtricitabine in Patients with HIV/HBV Co-Infection Conditions: HIV-1 infection; Hepatitis B virus infection
Cellulose Sulfate (CS) Gel and HIV in Nigeria Conditions: HIV Infections; Gonorrhea; Chlamydia Infections
Study of Tenofovir Disoproxil Fumarate (TDF) for Prevention of HIV Condition: HIV Infections
HBV FDA-approved Treatment
Epivir-HBV Intron A Hepsera Baraclude Pegasys
Experimental Treatments - Monotherapies -
• Experimental Treatments (chart) • ACH-126, 443 • Beta Interferon • Emtricitibine; FTC • Famvir (famciclovir) • HBV/MF59 • Immunoglobulin • L-dT (telbivudine) • L-FMAU (Clevudine) • Oxymatrine • PEG-Intron • Pradefovir • RNA interference • Tenofovir (viread) • valLdC (Valtorcitabine) • Viread for Lamivudine- resistant HBV • Zadaxin (Thymosin) • Alternative Treatments
Experimental Treatments - Combination -
• Experimental Treatments (chart) • HBV Vaccine + Epivir-HBV • Epivir-HBV (lamivudine) + Hepatitis B Immunoglobulin (HBIg) • Epivir-HBV + Famvir • Epivir-HBV + Hepsera • Hepsera + Hepatitis B Immunoglobulin (HBIg) • Interferon alfa (Intron A) + Epivir-HBV • Telbivudine + Epivir-HBV • Pegasys + Epivir-HBV • PEG-Intron + Epivir-HBV • PEG-Intron + Hepsera
HBV Articles by Topic
• Adefovir Drug Resistance • Age • African Americans • ALT / AST • Alternative Treatment • Artificial Liver Support System • Chilren / Infants • Clevudine • Conference Reports • Dosing • Drug Resistance • End of Treatment Response • Epidemiology • FDA-approved Treatment • Epivir-HBV • Epivir-HBV-resistant virus • Epivir Pulse Therapy • Extra hepatic Events • Experimental Treatment • Fulminant hepatitis • Genotypes • GGT (laboratory value) • Guidelines • HBeAg-negative/positive • HBsAg-negative/positive • HBIG • HBV Seroprevalence • HBV DNA • HBV Recurrence • Hepsera • Hep B immune globulin • Immunotherapy • Intron A • Lamivudine Pulse Therapy • Liver Complications - Hepatocellular Carcinoma - Histology - Decompensation - Fibrosis - Steatosis - Cirrhosis • Miscellaneous • Morbidity and Mortality • Natural History • Nephrotoxicity (kidney toxicity) • Non Hodgkin's Lymphoma • Non Responders • Occult HBV • Pancreatic Cancer • Pharmacokinetics • Precore Mutant • Prevention • Primary HBV Infectiony • Quality of Life • Renal Transplantation • Rescue (salvage) Therapy • Resistance • Response to Treatment • Risk Factors • Seroconversion • Side effects • Smoking • Superinfection • Sustained Response Rates • Switch Studies • Tests - ALT / AST - Biopsy - FDA- Approved Tests • Therapies and Vaccines Chart • Transplantation • Transmission • Vaccines • Vaccine Boosters • Viral Clearance • YMDD Mutants
